Tongfang Kontafarma Holdings Limited (formerly known as Allied Cement Holdings Limited), was incorporated in the Cayman Islands in March 2011 and its shares has been listed on The Stock Exchange of Hong Kong Limited since 18 January 2012 (Stock Code: 1312).

The Company, through its subsidiaries, is principally engaged in manufacturing and sales of cement, clinker and slag, trading of cement and provision of technical services with operations in Shandong province and Shanghai in the PRC. Apart from promoting the current strategies to improve the core competitiveness of the existing businesses, the Company and its subsidiaries (the "Group"), has been actively exploring the medical, pharmaceutical and health industry business and other related investment opportunities. The name of the Company was changed from Allied Cement Holdings Limited to Tongfang Kontafarma Holdings Limited in July 2016 to reflect the expansion of the Group's business scope and diversified operations with a more accurate display of the Group's strategic positioning. The Group acquired the equity interest in 同方藥業集團有限公司 Tongfang Pharmaceutical Group Co., Ltd* (formerly known as 北京紫光製藥有限公司 Beijing Ziguang Pharmaceutical Co., Ltd.*) in July 2016, Tongfang Pharmaceutical Group Co., Ltd.* is engaged in manufacturing and sales of prescription drugs, laboratory related-products and other pharmaceutical-related businesses in Beijing, Chongqing, Shaanxi and Tibet in the PRC. In 2017, the Group also acquired the equity interest in TFKT True Holdings and True Yoga Holdings Limited, the acquired companies and their subsidiaries engaged in operating of fitness centres and provision of consultation services for fitness and health activities in Singapore, the PRC and Taiwan.

*For identification purpose only

Back to top